The drug seizure agreement between India and the EU, intended to stop European customs officials from seizing legitimate generics on their way to Africa and Latin America by claiming patent infringement, may be for naught. And India may be facing the same issue on a larger scale in the likely soon-to-be enacted Anti-Counterfeiting Trade Agreement. ACTA still promotes an EU-style legal regime that would facilitate cross-border seizures of legitimate and lawful generic medicines that transit through any member country, says one law professor. Article